GrowingStockReport.com

NASDAQ Gainers Watch List: Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) and Athersys, Inc. (NASDAQ:ATHX) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 04/11/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) and Athersys, Inc. (NASDAQ:ATHX).

Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) operates as a development stage biotechnology company in the United States is currently up (+2.45%) on 451,009 shares traded after RAPTOR PHARMACEUTICAL CORP Filed SEC form 8-K, Entry into a Material Definitive Agreement. Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) is currently up (+37.93%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Raptor Pharmaceuticals Corp. (NASDAQ:RPTP)

Athersys, Inc. (NASDAQ:ATHX) a biotechnology company that focuses on the research and development in the field of regenerative medicine is currently up (+4.47%) on 932,526 shares traded after Athersys Announced to Present at Regen Med Investor Day 2013 in New York on Wednesday, April 17. Athersys, Inc. (NASDAQ:ATHX) is currently up (+97.89%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Athersys, Inc. (NASDAQ:ATHX)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com